About The Study
The study is to learn more about how the investigational drug which is a metered-dose inhaler containing budesonide, glycopyrronium and formoterol fumarate (BGF MDI), can improve asthma symptoms. We would also like to better understand the studied disease and associated health problems.
Eligibility Criteria
- Are 12 to 80 years of age
- Have a documented medical history of asthma in the past 1 year
- Are on an asthma treatment regimen for at least 4 weeks
- Had 1 asthma exacerbation in the past 12 months requiring corticosteroid
- Have not smoked within the past 6 months (e-cigarettes, vaped, tobacco or use of cannabis)
- Body mass index of less than 40kg/m
